|
| Main focus | Main findings | Reference |
|
| Effect of mistletoe therapy in reduction of chemotherapy adverse reaction | HRQoL improved in breast cancer patients | [76] |
| Evaluate efficacy of mistletoe on cancer | Chemotherapy side effects were reduced and HROoL was improved | [77] |
| Analyze safety and effectiveness of mistletoe in cancer patients | Weak evidence of positive effect on survival of cancer patients was observed; some evidence on the improvement of HRQoL in breast cancer patients was found | [78] |
| Evaluate the Influence of complementary mistletoe treatment on HRQoL and survival of breast cancer patients | Iscador therapy in addition to chemotherapy might prolong survival and HRQoL | [79] |
| Effectiveness of mistletoe on cancer patients with respect to HRQoL associated measures | Most of the studies showed improved HRQoL; four studies showed no differences | [81] |
| Investigate effectiveness of mistletoe on cancer | Most of the trials exhibited beneficial effects; three showed no effect; one indicated negative effect | [82] |
| Determine impact ofIscador on survival rates of cancer patients | Survival rates were enhanced | [83] |
| Analyze preclinical and clinical trials on effectiveness of V.album on cancer | Positive impacts were observed | [84] |
| Efficacy of Iscador on HRQoL in cancer patients | Some evidence of positive effect was found | [85] |
| Retrolective on effectiveness of mistletoe on cancer patients | Positive effects were found; retrolective study design was limited | [86] |
| Documentation of observational studies and clinical trials with Iscador | Survival rates were enhanced; tumor in breast cancer patients who received Iscador was completely or partially remitted | [87] |
|
